Technology Commercialization Office

Showing 2 result(s) for "Infectious Diseases"



A novel method to increase vaccine effectiveness for TB

Inh2-B1 serves as a therapeutically important “antibiotic-resistance-breaker,” which enhances the bactericidal activity of Ceftriaxone/Cefotaxime against highly pathogenic MDRSA infection.